Volume 21, Issue 1 914719 pp. e1-e3
Open Access

Severe Asthma Associated with Myasthenia Gravis

Natasha Satkunam

Natasha Satkunam

University of Queensland Faculty of Health Science School of Medicine Brisbane, Australia , uq.edu.au

Search for more papers by this author
Zaeem A Siddiqi

Zaeem A Siddiqi

Department of Medicine Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta, Canada , ualberta.ca

Search for more papers by this author
Dilini Vethanayagam

Corresponding Author

Dilini Vethanayagam

Department of Medicine Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta, Canada , ualberta.ca

Search for more papers by this author
First published: 01 January 2014
Citations: 6

Abstract

Severe asthma constitutes a subgroup of approximately 10% of all asthma cases. Approximately one-half of these individuals have a refractory form of the disease in which atopy and T-helper cell 2-skewed immunological response may not be as closely linked to the disease as in other phenotypes of asthma. This suggests that not all asthma is explained by a T-helper cell 2-skewed immunological response, and that other immunological mechanisms may be important in this category of nonatopic asthma. The authors present a case involving a 55-year-old Caucasian man with nonatopic, adult-onset asthma, nonsteroidal anti-inflammatory drug sensitivity and idiopathic urticaria. This individual presented two years following his initial asthma diagnosis with diplopia and mild ptosis, and was subsequently diagnosed with seropositive myasthenia gravis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.